Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance

Margaret E Tome, Jennifer B. Frye, Donna L. Coyle, Elaine L. Jacobson, Betty K. Samulitis, Katerina Dvorak, Robert T Dorr, Margaret M Briehl

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Chronic inflammation increases lymphoma risk. Chronic inflammation exposes cells to increased reactive oxygen species (ROS). Constant exposure to ROS selects for oxidative stress-resistant cells with upregulated anti-oxidant defense enzymes. The impact of oxidative stress resistance on the redox biology and chemotherapy response in lymphoma has not been rigorously tested. To measure the effect of anti-oxidant defense enzyme upregulation in lymphoid cells, we created oxidative stress-resistant WEHI7.2 thymic lymphoma cell variants. We selected a population of WEHI7.2 cells for resistance to hydrogen peroxide and constructed catalase-overexpressing WEHI7.2 transfectants. The WEHI7.2 variants had: i) increased catalase and total superoxide dismutase activities; ii) an altered GSSG/2GSH redox potential; iii) a more oxidized NADP +/NADPH pool; and iv) increased phase 2 enzymes, NAD(P)H:quinone oxidoreductase and glutathione S-transferases μ and π. Regression analysis showed a correlation between the GSSG/2GSH redox potential and the increased phase 2 enzyme activities. As predicted from the anti-oxidant defense enzyme profile, the variants were more resistant to the oxidants hydrogen peroxide and paraquat. The variants exhibited resistance to the common lymphoma chemotherapeutics, cyclophosphamide, doxorubicin, vincristine and glucocorticoids. These data indicate that chronic ROS exposure results in lymphoid cells with multiple changes in their redox biology and a chemoresistance phenotype. These data further suggest that lymphomas that arise at the site of chronic inflammation develop chemoresistance due to a combination of drug detoxification and removal of ROS.

Original languageEnglish (US)
Pages (from-to)845-852
Number of pages8
JournalExperimental and Therapeutic Medicine
Volume3
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Oxidants
Lymphoma
Oxidation-Reduction
Reactive Oxygen Species
Enzymes
Oxidative Stress
Glutathione Disulfide
Inflammation
NADP
Catalase
Hydrogen Peroxide
Lymphocytes
Paraquat
Vincristine
Drug Combinations
Glutathione Transferase
NAD
Doxorubicin
Cyclophosphamide
Glucocorticoids

Keywords

  • Catalase
  • Lymphoma
  • Reactive oxygen species

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research
  • Immunology and Microbiology (miscellaneous)

Cite this

Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance. / Tome, Margaret E; Frye, Jennifer B.; Coyle, Donna L.; Jacobson, Elaine L.; Samulitis, Betty K.; Dvorak, Katerina; Dorr, Robert T; Briehl, Margaret M.

In: Experimental and Therapeutic Medicine, Vol. 3, No. 5, 05.2012, p. 845-852.

Research output: Contribution to journalArticle

Tome, Margaret E ; Frye, Jennifer B. ; Coyle, Donna L. ; Jacobson, Elaine L. ; Samulitis, Betty K. ; Dvorak, Katerina ; Dorr, Robert T ; Briehl, Margaret M. / Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance. In: Experimental and Therapeutic Medicine. 2012 ; Vol. 3, No. 5. pp. 845-852.
@article{9ca02e77d785404eb3bed446ad3ee795,
title = "Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance",
abstract = "Chronic inflammation increases lymphoma risk. Chronic inflammation exposes cells to increased reactive oxygen species (ROS). Constant exposure to ROS selects for oxidative stress-resistant cells with upregulated anti-oxidant defense enzymes. The impact of oxidative stress resistance on the redox biology and chemotherapy response in lymphoma has not been rigorously tested. To measure the effect of anti-oxidant defense enzyme upregulation in lymphoid cells, we created oxidative stress-resistant WEHI7.2 thymic lymphoma cell variants. We selected a population of WEHI7.2 cells for resistance to hydrogen peroxide and constructed catalase-overexpressing WEHI7.2 transfectants. The WEHI7.2 variants had: i) increased catalase and total superoxide dismutase activities; ii) an altered GSSG/2GSH redox potential; iii) a more oxidized NADP +/NADPH pool; and iv) increased phase 2 enzymes, NAD(P)H:quinone oxidoreductase and glutathione S-transferases μ and π. Regression analysis showed a correlation between the GSSG/2GSH redox potential and the increased phase 2 enzyme activities. As predicted from the anti-oxidant defense enzyme profile, the variants were more resistant to the oxidants hydrogen peroxide and paraquat. The variants exhibited resistance to the common lymphoma chemotherapeutics, cyclophosphamide, doxorubicin, vincristine and glucocorticoids. These data indicate that chronic ROS exposure results in lymphoid cells with multiple changes in their redox biology and a chemoresistance phenotype. These data further suggest that lymphomas that arise at the site of chronic inflammation develop chemoresistance due to a combination of drug detoxification and removal of ROS.",
keywords = "Catalase, Lymphoma, Reactive oxygen species",
author = "Tome, {Margaret E} and Frye, {Jennifer B.} and Coyle, {Donna L.} and Jacobson, {Elaine L.} and Samulitis, {Betty K.} and Katerina Dvorak and Dorr, {Robert T} and Briehl, {Margaret M}",
year = "2012",
month = "5",
doi = "10.3892/etm.2012.487",
language = "English (US)",
volume = "3",
pages = "845--852",
journal = "Experimental and Therapeutic Medicine",
issn = "1792-0981",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance

AU - Tome, Margaret E

AU - Frye, Jennifer B.

AU - Coyle, Donna L.

AU - Jacobson, Elaine L.

AU - Samulitis, Betty K.

AU - Dvorak, Katerina

AU - Dorr, Robert T

AU - Briehl, Margaret M

PY - 2012/5

Y1 - 2012/5

N2 - Chronic inflammation increases lymphoma risk. Chronic inflammation exposes cells to increased reactive oxygen species (ROS). Constant exposure to ROS selects for oxidative stress-resistant cells with upregulated anti-oxidant defense enzymes. The impact of oxidative stress resistance on the redox biology and chemotherapy response in lymphoma has not been rigorously tested. To measure the effect of anti-oxidant defense enzyme upregulation in lymphoid cells, we created oxidative stress-resistant WEHI7.2 thymic lymphoma cell variants. We selected a population of WEHI7.2 cells for resistance to hydrogen peroxide and constructed catalase-overexpressing WEHI7.2 transfectants. The WEHI7.2 variants had: i) increased catalase and total superoxide dismutase activities; ii) an altered GSSG/2GSH redox potential; iii) a more oxidized NADP +/NADPH pool; and iv) increased phase 2 enzymes, NAD(P)H:quinone oxidoreductase and glutathione S-transferases μ and π. Regression analysis showed a correlation between the GSSG/2GSH redox potential and the increased phase 2 enzyme activities. As predicted from the anti-oxidant defense enzyme profile, the variants were more resistant to the oxidants hydrogen peroxide and paraquat. The variants exhibited resistance to the common lymphoma chemotherapeutics, cyclophosphamide, doxorubicin, vincristine and glucocorticoids. These data indicate that chronic ROS exposure results in lymphoid cells with multiple changes in their redox biology and a chemoresistance phenotype. These data further suggest that lymphomas that arise at the site of chronic inflammation develop chemoresistance due to a combination of drug detoxification and removal of ROS.

AB - Chronic inflammation increases lymphoma risk. Chronic inflammation exposes cells to increased reactive oxygen species (ROS). Constant exposure to ROS selects for oxidative stress-resistant cells with upregulated anti-oxidant defense enzymes. The impact of oxidative stress resistance on the redox biology and chemotherapy response in lymphoma has not been rigorously tested. To measure the effect of anti-oxidant defense enzyme upregulation in lymphoid cells, we created oxidative stress-resistant WEHI7.2 thymic lymphoma cell variants. We selected a population of WEHI7.2 cells for resistance to hydrogen peroxide and constructed catalase-overexpressing WEHI7.2 transfectants. The WEHI7.2 variants had: i) increased catalase and total superoxide dismutase activities; ii) an altered GSSG/2GSH redox potential; iii) a more oxidized NADP +/NADPH pool; and iv) increased phase 2 enzymes, NAD(P)H:quinone oxidoreductase and glutathione S-transferases μ and π. Regression analysis showed a correlation between the GSSG/2GSH redox potential and the increased phase 2 enzyme activities. As predicted from the anti-oxidant defense enzyme profile, the variants were more resistant to the oxidants hydrogen peroxide and paraquat. The variants exhibited resistance to the common lymphoma chemotherapeutics, cyclophosphamide, doxorubicin, vincristine and glucocorticoids. These data indicate that chronic ROS exposure results in lymphoid cells with multiple changes in their redox biology and a chemoresistance phenotype. These data further suggest that lymphomas that arise at the site of chronic inflammation develop chemoresistance due to a combination of drug detoxification and removal of ROS.

KW - Catalase

KW - Lymphoma

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84858656653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858656653&partnerID=8YFLogxK

U2 - 10.3892/etm.2012.487

DO - 10.3892/etm.2012.487

M3 - Article

AN - SCOPUS:84858656653

VL - 3

SP - 845

EP - 852

JO - Experimental and Therapeutic Medicine

JF - Experimental and Therapeutic Medicine

SN - 1792-0981

IS - 5

ER -